Post-Brexit Britain and the rivers of green for Australian cannabis companies by Elisabetta Faenza June 9, 2021June 9, 2021 With a post-Brexit free trade agreement with the UK in the offing, LeafCann CEO and MCIA […]
‘Reputation arrives on foot, and leaves on horseback’: industry urged not to rush to profitability by Steve Jones March 18, 2021March 24, 2021
Exclusive: Department of Health considers making imported medical cannabis meet GMP standards by Rhys Cohen October 6, 2020October 6, 2020
Put patients first and the whole industry will thrive by Steve Jones September 26, 2020October 21, 2020
Major doubts remain as industry reacts to CBD down scheduling by Steve Jones September 10, 2020September 14, 2020
LeafCann and The Green Organic Dutchman sign exclusive distribution agreement by Emma Castle September 3, 2020April 9, 2021
The Biz Interview: LeafCann chief executive Elisabetta Faenza by Steve Jones August 19, 2020August 25, 2020
Analysis: why government underfunding is putting Australian medical cannabis users at risk by Steve Jones August 12, 2020August 13, 2020
